submit to the journals
Leading the Debate on the Advances in Healthcare
ECTRIMS Highlights
flipper_slider
ECTRIMS 2017 – Tanuja Chitnis Interview
Tanuja Chitnis talks to us about MS and nutrition/supplementation. 1. What is the role of...
ECTRIMS 2017 – Oscar Fernández Interview
Oscar Fernández discusses patient adherence with smart devices for the treatment of...
ECTRIMS 2017 – Angelo Ghezzi Interview
Angelo Ghezzi discusses quality of life in adolescent patients with MS using the RebiSmartTM smart...
ECTRIMS 2017 – Cris Constantinescu Interview
Our Editor-in-Chief of European Neurological Review, Cris Constantinescu, shares his insights and...
Editor's Choice
Jeffrey Cohen talks to us about proposed new updates to the McDonald criteria for MS diagnosis.
1. Why are revisions to the McDonald criteria needed? (0:05)
2. What are the limitations of the current criteria in...
ECTRIMS Highlights Videos
Tanuja Chitnis talks to us about MS and nutrition/supplementation.
1. What is the role of polyunsaturated fatty acid (PUFA) intake in multiple sclerosis (MS) risk? (0:05)
2. What dietary factors are thought to be important in pediatric MS? (0:42)
3. How may patients with MS optimize their diet...
Oscar Fernández discusses patient adherence with smart devices for the treatment of MS.
1. What is the approximate rate of non adherence to injectable disease-modifying drugs and what are the reasons for this? (0:05)
2. What features of the RebiSmartTM device are designed to improve adherence...
Angelo Ghezzi discusses quality of life in adolescent patients with MS using the RebiSmartTM smart device.
1. What was the rationale for the FUTURE study? (0:05)
2. Discuss the results of the study, and the impact of the RebiSmartTM device on school functioning, quality of life and adherence. (...
Our Editor-in-Chief of European Neurological Review, Cris Constantinescu, shares his insights and highlights from ECTRIMS-ACTRIMS 2017.
1. What have been the most significant recent developments in MS? (0:05)
2. Which presentations/data at ECTRIMS-ACTRIMS have interested you the most? (02:39)...
Jürg Kesselring shares what he considers to be the most promising areas of MS research and his highlights from ECTRIMS-ACTRIMS 2017. Part 2 of 2.
View Part 1 here.
1. What are the most promising areas of MS research? (0:05)
2. Which presentations/data at ECTRIMS–ACTRIMS have interested you...
Jürg Kesselring discusses recent developments and unmet needs in MS. Part 1 of 2.
View Part 2 here.
1. What have been the most significant recent developments in MS? (0:05)
2. Discuss the current unmet needs and/or the challenges you face as an MS specialist (3:35)
Speaker disclosures:...
Kumaran Deiva shares his insights and highlights on paediatric MS from ECTRIMS-ACTRIMS 2017.
1. What have been the most significant recent developments in paediatric MS? (0:05)
2. Discuss the current unmet needs and/or the challenges you face as a paediatric MS specialist (0:38)
3. What are...
Mark Freedman shares what he considers to be the most promising areas of MS research and his highlights from ECTRIMS-ACTRIMS 2017. Part 2 of 2.
View Part 1 here.
1. What are the most promising areas of MS research? (0:05)
2. Which presentations/data at ECTRIMS–ACTRIMS have interested you the...
Mark Freedman discusses recent developments and unmet needs in MS. Part 1 of 2.
View Part 2 here.
1. What have been the most significant recent developments in MS? (0:05)
2. Discuss the current unmet needs and/or the challenges you face as an MS specialist (1:05)
Speaker disclosures: Mark...
Nicolas Dubuisson talks to us about the topic of his presentation, the development of a smartphone application that enables visual function in MS to be self-monitored.
1. How prevalent is subclinical optic nerve involvement in MS and why is its assessment important? (0:05)
2. What are the...
David Hafler shares his insights and highlights from ECTRIMS-ACTRIMS 2017.
1. What have been the most significant recent developments in MS? (0:05)
2. Discuss the current unmet needs and/or the challenges you face as an MS specialist (0:47)
3. What are the most promising areas of MS research...
Dawn Langdon shares her insights on significant recent developments including the Brief International Cognitive Assessment for MS (BICAMS), a fast, easy-to-administer and already widely validated neuropsychological battery for cognition in MS, as well as an important new study on Benefit and Risk...
Jeffrey Cohen talks to us about proposed new updates to the McDonald criteria for MS diagnosis.
1. Why are revisions to the McDonald criteria needed? (0:05)
2. What are the limitations of the current criteria in special populations (i.e. paediatric, Asian and Latin American people)? (0:38...
We are pleased to introduce Cris Constantinescu as the new Editor in Chief for the European Neurological Review. In this interview Dr Constantinescu discusses his research interests and his aims for the journal over the next year.
INTRODUCING THE NEW EUROPEAN NEUROLOGICAL REVIEW EDITOR-IN-CHIEF...
Cris Constantinescu discusses the most exciting developments in the neurology field from the past year.
FILMED AT THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) ANNUAL MEETING, SEPTEMBER 2016
WHAT DO YOU CONSIDER THE MOST EXCITING DEVELOPMENTS IN NEUROLOGY...
